| Identification | Back Directory | [Name]
RAD51-IN-17 | [CAS]
2101739-18-6 | [Synonyms]
AFN39186
RAD5-IN-1
RAD51-IN-1
RAD51-IN-17
RAD51-IN-17(AFN39186)
4(3H)-Quinazolinone, 3-[(4-chlorophenyl)methyl]-2-[(1E)-2-(3-pyridinyl)ethenyl]-
cancer,inhibit,tumor cell,chemotherapy,RAD51 IN 1,Inhibitor,RAD51,DNA damage,RAD-51-IN-1,RAD51IN1 | [Molecular Formula]
C22H16ClN3O | [MDL Number]
MFCD34469364 | [MOL File]
2101739-18-6.mol | [Molecular Weight]
373.83 |
| Chemical Properties | Back Directory | [Boiling point ]
569.9±60.0 °C(Predicted) | [density ]
1.24±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 62.5 mg/mL (167.19 mM; Need ultrasonic) | [form ]
Solid | [pka]
4.33±0.11(Predicted) | [color ]
Yellow to orange |
| Hazard Information | Back Directory | [Uses]
RAD51-IN-1, a derivative of B02, is a potent inhibitor of RAD51. RAD51-IN-1 can be used for cancer research[1]. | [storage]
Store at -20°C | [References]
[1] Ambber Ward, et al. Quinazolinone derivatives as inhibitors of homologous recombinase RAD51. Bioorg Med Chem Lett. 2017 Jul 15;27(14):3096-3100. DOI:10.1016/j.bmcl.2017.05.039 |
|
| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
|